Summary: Researchers report that a single exposure to cocaine produces profound and lasting structural changes in the genome of key brain cells. Using three-dimensional genome mapping in mice, the team found that one dose physically reshapes the DNA folding inside reward-related neurons of the ventral tegmental area, leaving a persistent genetic “scar” that could increase susceptibility to addiction for at least two weeks.
Key Facts
- The vulnerability window: While most people do not develop clinical addiction after a single use of cocaine, many become more vulnerable after a second exposure or repeated use. The researchers used mouse models to locate where the brain stores the memory of that first exposure.
- Rewiring the reward core: Applying genome architecture mapping (GAM), the team showed that one cocaine dose dramatically alters the three-dimensional arrangement of the genome inside dopaminergic neurons of the ventral tegmental area (VTA), the midbrain hub that regulates reward, motivation, and pleasure.
- Persistent genetic scar: Structural changes appeared within 24 hours and remained detectable two weeks after a single exposure. Some alterations were even more pronounced at day 14 than immediately after exposure.
- Chromatin insulation shift: The study identified the sudden emergence of about 1,700 new chromatin domain insulation regions—structural boundaries that influence gene activity—alongside the loss of roughly 1,100 existing ones.
- Addiction-linked neuropeptides rise: Gene expression analysis revealed increased production of specific neuropeptides associated with addictive behavior, while genes involved in routine cellular maintenance were downregulated.
- Implications for recreational use: Independent experts emphasize that because these deep-brain processes are not measurable in living humans, careful animal studies like this provide critical insight. A single cocaine exposure altering 3D genome architecture challenges the notion that occasional recreational use is harmless.
Source: FENS
Overview: A team led by Ana Pombo, Bloomberg Distinguished Professor at Johns Hopkins University and Guest Group Leader at the Max Delbrück Centre for Molecular Medicine, presented these findings at the FENS Forum 2026. Their work used advanced genomic mapping in mice to examine how the brain records an initial exposure to cocaine and why later exposures can trigger addiction even after long intervals.
Cocaine is a highly addictive stimulant linked to short-term anxiety and paranoia and to long-term harms including cardiovascular injury and deteriorating mental health. Global estimates show cocaine use is widespread, underlining the importance of understanding how even a single exposure alters brain function.
Professor Pombo explained that the VTA contains dopaminergic neurons central to the brain’s reward circuitry and that cocaine’s ability to hijack this circuitry has long been recognized. What this study adds is evidence that the drug physically changes how DNA is folded in these neurons—changes that can persist well beyond the acute effects of the drug.
The researchers used genome architecture mapping to capture the three-dimensional organization of chromatin inside individual cells. While every cell contains the same genetic code, the way DNA folds in three dimensions determines which genes are accessible and active. Comparing exposed and unexposed animals, the team observed large-scale reconfiguration of genomic contacts and insulation boundaries specifically in VTA dopaminergic neurons.
Beyond the structural shifts, transcriptomic analysis showed selective activation of genes that encode neuropeptides implicated in addictive behaviors, while many genes supporting normal cell function were repressed. These coordinated structural and functional changes form a pattern consistent with a brain primed for stronger responses to later drug encounters.
Professor Pombo commented: “A single exposure to cocaine appears to ‘rewire’ the genome of these crucial brain cells. The depth and persistence of these changes were unexpected and suggest the drug leaves a durable molecular imprint that could increase vulnerability to subsequent use.” She added that further work is needed to determine whether these changes are reversible or permanent and how they relate to addiction risk in humans.
Professor Christina Dalla, chair of the FENS Forum communication committee and not involved in the study, noted the difficulty of investigating these mechanisms directly in humans. She emphasized that the mouse findings highlight a serious risk: even occasional use of cocaine can alter genome structure in reward circuits and potentially raise the long-term risk of addiction. Understanding these mechanisms further may help explain individual differences in susceptibility and inform new treatment approaches.
Key Questions Answered:
A: Powerful psychoactive drugs like cocaine do more than create a short-lived chemical surge. They alter chromatin folding—the three-dimensional arrangement of DNA inside the nucleus—which controls which genes are turned on or off. This study shows a single exposure can reconfigure genome architecture in reward neurons, producing structural changes that last for at least two weeks.
A: The VTA is a midbrain region rich in dopaminergic neurons that regulate reward, motivation, and pleasure. Because cocaine targets these neurons, structural changes to their genome can directly affect how the brain processes reward and can shift baseline responses to future stimuli, increasing addiction risk.
A: The findings challenge the common belief that a single or occasional use is harmless. By demonstrating persistent, deep changes in genome structure after one exposure, the study indicates that even limited use can modify brain biology in ways that may lower resistance to later addiction.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this neuroscience and genetics research news
Author: Kerry Noble
Source: FENS
Contact: Kerry Noble – FENS
Image credit: Neuroscience News
Original research presentation: FENS Forum 2026